HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Evidence Based Prevention of AD

Due to various study designs with variable objectives and believability, evidence on preventing Alzheimer's disease (AD) is difficult to understand. Over the last few decades, there have been significant global efforts to update and upgrade the knowledge on how to prevent Alzheimer's disease (AD), which accounts for roughly two-thirds of all dementia cases and affects up to 20% of people over the age of 80. Nonetheless, inconsistency among conclusions and varying levels of credibility resulting from the large variety of study methods are major concerns in the discipline. Prevention programming that is evidence-based (EB) comprises of interventions and policies that have been proved to be successful in preventing the initiation and continuation of substance use and other problem behaviors through rigorous evaluations.

  • Pathogenesis and Clinical Features in AD
  • Pharmacological Treatment
Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong-Xiao Wang

Yong-Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jun Hua

Jun Hua

Johns Hopkins University School of Medicine, United States

Submit your abstract Today

Watsapp